Transcriptomics analysis revealed that TAZ regulates the proliferation of KIRC cells through mitophagy
Authors:
Open Access
- 19 February 2024
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 24 (1) , 1-12
Abstract
Transcriptional Co-Activator with PDZ-Binding Motif (TAZ, also known as WWTR1) is a downstream effector of the Hippo pathway, involved in the regulation of organ regeneration and cell differentiation in processes such as development and regeneration. TAZ has been shown to play a tumor-promoting role in various cancers. Currently, many studies focus on the role of TAZ in the process of mitophagy. However, the molecular mechanism and biological function of TAZ in renal clear cell carcinoma (KIRC) are still unclear. Therefore, we systematically analyzed the mRNA expression profile and clinical data of KIRC in The Cancer Genome Atlas (TCGA) dataset. We found that TAZ expression was significantly upregulated in KIRC compared with normal kidney tissue and was closely associated with poor prognosis of patients. Combined with the joint analysis of 36 mitophagy genes, it was found that TAZ was significantly negatively correlated with the positive regulators of mitophagy. Finally, our results confirmed that high expression of TAZ in KIRC inhibits mitophagy and promotes KIRC cell proliferation. In conclusion, our findings reveal the important role of TAZ in KIRC and have the potential to be a new target for KIRC therapy.Keywords
Funding Information
- National Natural Science Foundation of China (22076138, 22076138, 22076138, 22076138)
- Tuoxin Project Foundation of First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (2020054, 2020054)
This publication has 21 references indexed in Scilit:
- Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and CarcinogenesisGastroenterology, 2017
- Mitophagy: Link to cancer development and therapyBiochemical and Biophysical Research Communications, 2017
- Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer TherapyGenes, 2016
- YAP/TAZ at the Roots of CancerCancer Cell, 2016
- Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activationThe EMBO Journal, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Autophagy in infection, inflammation and immunityNature Reviews Immunology, 2013
- The Hippo pathway and human cancerNature Reviews Cancer, 2013
- Mechanisms of mitophagyNature Reviews Molecular Cell Biology, 2010
- Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging miceJournal of Clinical Investigation, 2010